Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVesuvius Regulatory News (VSVS)

Share Price Information for Vesuvius (VSVS)

Share Price is delayed by 15 minutes
Get Live Data
451.40    -4.80 (-1.05%)
Bid:
450.20
Ask:
452.00
Spread: 1.80 (0.40%)
Market Cap: £1.11b
VSVS Live PriceLast checked at - London Stock Exchange

Intraday Vesuvius Share Chart

Settlement with MacDermid, Inc

19 Feb 2015 14:02

RNS Number : 3761F
Vesuvius plc
19 February 2015
Β 

ο»Ώ

Β 

Β 

Β 

19 February 2015

Β 

Settlement with MacDermid, Inc. on legacy corporate activity

Vesuvius plc, a global leader in molten metal flow engineering notes the announcements made by Alent plc and Platform Speciality Products Corporation regarding the resolution of litigation arising out of corporate activity relating to Cookson Group plc's Performance Materials Division (now Alent plc) dating back to autumn 2006.

The pending litigation was noted in the contingent liability note of Vesuvius' 2013 Annual Report and Accounts. Pursuant to the terms of the demerger of Vesuvius and Alent plc, Vesuvius is required to contribute 50% of any net settlement liability. Vesuvius will pay US$10m (GBPΒ£6.4m) as its share of the full and final settlement of the litigation.

-----ENDS-----

For further information please contact:

Shareholder/analyst enquiries:

Vesuvius plc

Β 

Nicolas MatheΓ―, Group Head of Corporate Finance +44 (0) 207 822 0000

Virginia Skroski, Investor Relations Manager +44 (0) 207 822 0016

Β 

Media enquiries:

MHP Communications

Β 

John Olsen/ Tim Roundtree/ Jamie Ricketts +44 (0) 203 128 8100

Β 

Β 

About Vesuvius plc

Vesuvius is a global leader in molten metal flow engineering principally serving the steel and foundry industries.

Β 

We develop innovative and customised solutions, often used in extremely demanding industrial environments, which enable our customers to improve their manufacturing processes, enhance product quality and reduce energy consumption. These include flow control solutions, advanced refractories and other consumable products and - increasingly - related technical services including data capture.

Β 

We have a worldwide presence, serving our customers through a network of low-cost manufacturing plants located close to their own facilities, and by embedding our industry experts within their operations, all supported by our global technology centres.

Β 

Our core competitive strengths are our market and technology leadership, strong customer relationships, well established presence in developing markets and our global reach, all of which enable us to expand our addressable markets.

Β 

Our ultimate goal is to create value for our customers in order to deliver sustainable, profitable growth and provide our shareholders with a superior return on their investment whilst providing each of our employees with a safe workplace where he or she is recognised, developed and properly rewarded.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCPKCDKQBKDDBD
Date   Source Headline
11th Dec 202010:57 amRNSDirector/PDMR Shareholding
4th Dec 202010:14 amRNSHolding(s) in Company
30th Nov 20207:00 amRNSDirectorate Change
24th Nov 20203:07 pmRNSHolding(s) in Company
12th Nov 20207:00 amRNSTrading Update
22nd Oct 20209:50 amRNSHolding(s) in Company
20th Oct 20207:00 amRNSDividend Declaration
13th Oct 202011:30 amRNSTotal Voting Rights
6th Oct 202010:42 amRNSHolding(s) in Company
17th Sep 20207:00 amRNSDebt and Liquidity Update
2nd Sep 20208:31 amRNSDirector/PDMR Shareholding
30th Jul 20207:00 amRNSResults for the six months ended 30 June 2020
13th May 202012:44 pmRNSResult of AGM 2020
13th May 20207:00 amRNSAGM Trading Update
30th Apr 202011:28 amRNSChange in Director's Details
27th Apr 20206:13 pmRNSHolding(s) in Company
24th Apr 20205:13 pmRNSHolding(s) in Company
14th Apr 20205:37 pmRNSAnnual Financial Report 31 December 2019
9th Apr 20202:15 pmRNSTotal Voting Rights
6th Apr 20203:30 pmRNSStatement on COVID-19
2nd Apr 20209:45 amRNSHolding(s) in Company
24th Mar 20208:24 amRNSHolding(s) in Company
23rd Mar 20204:03 pmRNSDirector/PDMR Shareholding
13th Mar 202012:52 pmRNSDirector/PDMR Shareholding
13th Mar 202012:52 pmRNSDirector/PDMR Shareholding
11th Mar 202010:48 amRNSDirector/PDMR Shareholding
5th Mar 20204:45 pmRNSHolding(s) in Company
3rd Mar 20205:07 pmRNSHolding(s) in Company
27th Feb 20207:00 amRNSResults for the year ended 31 December 2019
20th Feb 20203:14 pmRNSHolding(s) in Company
3rd Feb 202011:53 amRNSChange in Director's Details
4th Dec 20194:24 pmRNSNon-executive Director Changes
15th Oct 20197:00 amRNSQ3 2019 Trading Update
2nd Oct 20195:36 pmRNSHolding(s) in Company
26th Sep 20196:00 pmRNSDirector/PDMR Shareholding
3rd Sep 201912:33 pmRNSTotal Voting Rights
26th Jul 201912:18 pmRNSHolding(s) in Company
25th Jul 20197:00 amRNSHalf-year Report
5th Jun 20191:20 pmRNSDirector/PDMR Shareholding
21st May 20194:03 pmRNSChange in Director's Details
15th May 20192:30 pmRNSResult of AGM
15th May 20197:00 amRNSAGM Statement
23rd Apr 20195:28 pmRNSDirector/PDMR Shareholding
15th Apr 20197:00 amRNSDirector/PDMR Shareholding
4th Apr 20195:21 pmRNSAnnual Financial Report
19th Mar 20194:35 pmRNSTotal Voting Rights
15th Mar 20193:45 pmRNSDirector/PDMR Shareholding
15th Mar 20193:45 pmRNSDirector/PDMR Shareholding
4th Mar 20194:30 pmRNSHolding(s) in Company
1st Mar 20194:42 pmRNSCompletion of the acquisition of CCPI Inc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.